Feasibility of Implementing Time-restricted Eating in Women With Mild Cognitive Impairment

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age45-95
SponsorJulie Pendergast

About this trial

This study will investigate the feasibility of implementing a time-restricted eating intervention in females with mild cognitive impairment. Targeted therapeutic interventions that improve cognitive impairment and delay onset of ADRD are particularly important for females, who have twice the lifetime risk of developing AD, compared to males.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Postmenopausal Women

Age 45-95

Diagnosis of mild cognitive impairment

Disqualifiers

Individuals prone to hypoglycemia

Liver disease

Taking medications that affect eating behaviors

Alcohol consumption of >2 drinks per day

Trial design

Design model

Single group

Treatments tested in this trial

  • Time-restricted eating

    Behavioral

    Subjects will be educated about the health benefits of time-restricted eating. Each subject will self-select a 10-hour (10hr +/- 1 hr) window aligned with their active phase during which they will consume all daily calories. Subjects will text the time of their first and last daily calories for the duration of the study.

Treatment groups

15 Participants
are divided into 1 treatment group
Group A: Time-restricted eatingExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Number of participants adhering to TRE protocol

The times of first and last meals will be collected from participants with an SMS texting system. Adherence defined as minimum 10 hour (+/- 1hr) TRE window 5 days per week.

Time frame
From enrollment to study completion up to approximately 8 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Julie Pendergast

Lead sponsor

University of Kentucky

Sponsor institution

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator